Covid-19-reserch-innovation
-
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read MoreNov 4, 2022
-
Research Spotlight: The Impact of COVID-19 Migration Patterns on Municipal Bonds
New Vanderbilt research explores the economic effects of pandemic-related migration patterns on municipal bonds. Read MoreSep 26, 2022
-
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. Read MoreMay 10, 2022
-
COVID-19 Sheds Light on the Overlooked Importance of Non-Essential Care Providers
New research from Vanderbilt Business highlights the importance of families, social workers, and chaplains to patient care. Read MoreMar 3, 2022
-
Gene variants increase risk of kidney failure in Black veterans with COVID-19: study
Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, possibly explaining some health disparities associated with COVID-19. Read MoreFeb 10, 2022
-
Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate
New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read MoreDec 24, 2021
-
“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19
Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19. Read MoreDec 10, 2021
-
Science and Strategy: Dr. Alex Jahangir draws on lessons from trauma surgery and management classes to lead Nashville’s response to COVID-19
As head of the Metro Nashville Coronavirus Task Force, Jahangir has helped coordinate local health systems and community groups, addressed the city at daily media briefings, set up COVID test sites and advised policymakers on combatting the virus, all while maintaining his normal duties at Vanderbilt. Read MoreOct 25, 2021
-
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week. Read MoreSep 2, 2021
-
Lessons Learned: Chancellor Daniel Diermeier draws on his academic expertise to explore Vanderbilt’s response to COVID-19
In a spirit of expanding our knowledge, I offer the following observations about how we made decisions as an organization, built trust within our community, and bolstered Vanderbilt’s reputation as an institution willing to confront difficult circumstances with hard work, compassion and commitment. Read MoreJul 27, 2021
-
Study finds genetic risk factors for severe COVID-19 illness
A massive worldwide collaboration including researchers from Vanderbilt University Medical Center (VUMC) has identified several genetic factors associated with SARS-CoV-2 infection and severe COVID-19 illness. Read MoreJul 8, 2021